Physicochemical Characterization of a New Crystal Form and Improvements in the Pharmaceutical Properties of the Poorly Water-Soluble Antiosteoporosis Drug 3,9-bis (N,N-Dimethylcarbamoy-loxy)- 5H-benzofuro[3,2-c]quinoline-6-one (KCA-098) by Solid Dispersion with Hydroxypropylcellulose

REFERENCES

• Kojima M., Tsutsumi N., Nagata H., Itoh F., Ujiie A., Kawashima K., Endo H., Ozaki M. Effect of KCA-098, a new benzofuroquinoline derivative, on bone mineral metabolism. Bio. Pharm. Bull. 1994; 17: 504–508
   PubMedGoogle Scholar
• Tsutsumi N., Kawashima K., Arai N., Nagata H., Kojima M., Ujiie A., Endo H. In vitro effect of KCA-098, a derivative of cumestrol, on bone resorption of fetal femurs. Bone Miner. 1994; 24: 201–209
   PubMedGoogle Scholar
• Tsutsumi N., Kawashima K., Nagata H., Itoh F., Arai N., Kojima M., Ujiie A., Endo H. Effect of KCA-098 on bone metabolism. comparison with those of ipriflavone, Jpn. J. Pharmacol. 1994; 65: 343–349
   PubMedGoogle Scholar
• Kawashima K., Inoue T., Tsutsumi N., Endo H. Effect of KCA-098 on the function of osteoblast-like cells and the formation of TRAP-positive multinucleated cells in a mouse bone marrow cell population, Biochem. Pharmacol. 1996; 51: 133–139
   Google Scholar
• Oda T., Notoya K., Gotoh M., Taketomi S., Fujisawa Y., Makino H., Sohda T. Synthesis of novel 2-benzothiopyran and 3-benzothiepin derivatives and their stimulatory effect on bone formation. J. Med. Chem. 1999; 42: 751–760
   PubMed Web of Science ®Google Scholar
• Veber D. F., Drake F. H., Gowen M. The new partnership of geomics and chemistry for accelerated drug development. Curr. Opin. Chem. Bid. 1997; 1: 151–156
   PubMed Web of Science ®Google Scholar
• Yamada T., Ikegami K., Toda M., Saito N., Iizuka K., Otagiri M. Polymorphism of 3,9-bis(N,N-dimethylcarbamoyl-oxy)-5H-benzofuro[3,2-c]quinoline-6-one (KCA-098), a new benzofuroquinoline derivative. Yakugaku Zasshi 1995; 115: 978–984
   PubMedGoogle Scholar
• Otsuka M., Kaneniwa N. Effects of grinding on the physicochemical properties of cephalexin. Chem. Pharm. Bull. 1984; 32: 1071–1079
   Web of Science ®Google Scholar
• Chaumeil J. C. Micronization: A method of improving the bioavailability of poorly soluble drugs, Methods Find. Exp. Clin. Pharmacol. 1998; 20: 211–215
   Web of Science ®Google Scholar
• Sugimoto M., Okagaki T., Narisawa S., Koide Y., Nakajima K. Improvement of dissolution characteristics and bioavailability of poorly water-soluble drugs by novel cogrinding method using water-soluble polymer. Int. J. Pharm. 1998; 160: 11–19
   Web of Science ®Google Scholar
• Ford J. L. The current status of solid dispersions. Pharm. Acta Helv. 1986; 6: 69–88
   Google Scholar
• Ventura C. A., Trirendi S., Puglisi G., Bousquet E., Panza L. Improvement of water solubility and dissolution rate of ursodeoxycholic acid and chenodeoxycholic acid by complexation with natural and modified β-cyclodextrins. Int. J. Pharm. 1997; 149: 1–13
   Web of Science ®Google Scholar
• Law S. L., Lo W. Y., Lin F. M., Chaing C. H. Dissolution and absorption of nifedipine in polyethylene glycol solid dispersion containing phosphatidylcholine. Int. J. Pharm. 1992; 84: 161–166
   Web of Science ®Google Scholar
• Kai T., Akiyama Y., Nomura N., Sato M. Oral absorption improvement of poorly soluble drug using solid dispersion technique. Chem. Pharm. Bull. 1996; 44: 568–571
   PubMed Web of Science ®Google Scholar
• Van den Mooter G., Augustijns P., Blaton N., Kinget R. Physicochemical characterization of solid dispersions of temazepam with polyethylene glycol 6000 and PVP K30. Int. J. Pharm. 1998; 164: 67–80
   Web of Science ®Google Scholar
• Rabasco A. M., Gines J. M., Fernandez-Arevalo M., Holgado M. A. Dissolution rate of diazepam from polyethylene glycol 6000 solid dispersions. Int. J. Pharm. 1991; 67: 201–205
   Web of Science ®Google Scholar
• Guyot M., Fawaz F., Bildet J., Bonini F., Lagueny A.-M. Physicochemical characterization and dissolution of norfloxacin/cyclodextrin inclusion compounds and PEG solid dispersion. Int. J. Pharm. 1995; 123: 53–63
   Web of Science ®Google Scholar
• Tantishaiyakul V., Kaewnopparat N., Ingkatawornwong S. Properties of solid dispersions of piroxicam in polyvinylpyrrolidone. Int. J. Pharm. 1999; 181: 143–151
   PubMed Web of Science ®Google Scholar
• Yagi N., Terashima Y., Kenmotsu H., Sekikawa H., Takada M. Dissolution behavior of probucol from solid dispersion systems of probucol-polyvinylpyrrolidone. Chem. Pharm. Bull. 1996; 44: 241–244
   Web of Science ®Google Scholar
• Johnson J. L., Holinej J., Williams M. D. Influence of ionic strength on matrix integrity and drug release from hydroxypropyl cellulose compacts. Int. J. Pharm. 1993; 90: 151–159
   Web of Science ®Google Scholar
• Takai T., Takayama K., Nambu N., Nagai T. Factors affecting the dissolution of griseofulvin dispersed in various water-soluble polymers. Chem. Pharm. Bull. 1984; 32: 1936–1941
   Web of Science ®Google Scholar
• Yuasa H., Ozeki T., Kanaya Y., Ueno M. Application of the solid dispersion method to the controlled release of medicine. VI. Release mechanism of a slightly water soluble medicine and interaction between flurbiprofen and hydroxypropyl cellulose in solid dispersion. Chem. Pharm. Bull. 1994; 42: 354–358
   Web of Science ®Google Scholar
• Chowdary K. P. R., Suresh Babu K. V. V. Dissolution, bioavailability and ulcerogenenic studies on solid dispersions of indomethacin in water soluble cellulose polymers. Drug Dev. Ind. Pharm. 1994; 20: 799–813
   Web of Science ®Google Scholar
• Ozeki T., Yuasa H., Kanaya Y. Application of the solid dispersion method to the controlled release of medicine. IX. Difference in the release of flurbiprofen from solid dispersions with poly(ethylene oxide) and hydroxypropyl cellulose and the interaction between medicine and polymers. Int. J. Pharm. 1997; 155: 209–217
   Web of Science ®Google Scholar
• Silverstein R. M., Bassler G. C., Morrill T. C. Spectrometric Identification of Organic Compounds. 5th, John Wiley and Sons Inc., New York 1991; 111–116
   Google Scholar
• Yakou S., Yamazaki S., Sonobe T., Nagai T., Sugihara M. Dissolution and bioavailability of phenytoin in phenytoin-polyvinylpyrrolidone-sodium deoxycholate coprecipitate. Chem. Pharm. Bull. 1986; 34: 3408–3414
   PubMedGoogle Scholar
• Yang Z., Yonemochi E., Seki H., Yano K., Yamamoto K. Molecular interaction in solvents between pharmaceutical excipients and water insoluble drug (R) -1-[2,3-dihydro - 1 - (2′-mehtylphenacyl) - 2 - oxo - 5 - phenyl-1H - 1,4 -benzodiazepin-3-yl]-3-(3-methylphenyl)urea. J. Pharm. Sci. Technol. Jpn. 1996; 56: 224–231
   Google Scholar
• Tantishaiyakul V., Kaewnopparat N., Ingkatawornwong S. Properties of solid dispersions of piroxicam in polyvinylpyrrolidone K-30. Int. J. Pharm. 1996; 143: 59–66
   Web of Science ®Google Scholar
• Akbuga J., Gursoy A., Kendi E. The preparation and stability of fast release furosemide-PVP solid dispersion. Drug Dev. Ind. Pharm. 1988; 14: 1439–1464
   Web of Science ®Google Scholar
• Ford J. L. The effect of particle size on some in vitro and in vivo properties of indomethacin-polyethylene glycol 6000 solid dispersion. Drug Dev. Ind. Pharm. 1986; 12: 1777–1793
   Google Scholar
• Pandit J. K., Khakurel B. K. In vitro and in vivo evaluation of some fast release dosage forms of hydrochlorothiazide. Drug Dev. Ind. Pharm. 1984; 10: 1709–1724
   Web of Science ®Google Scholar